Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ackman Still Confident Herbalife Ltd. (HLF) Will Fall; Discusses Mondelez International Inc (MDLZ), Valeant Pharmaceuticals Intl Inc (VRX)

Page 1 of 2

Renowned activist investor Bill Ackman of Pershing Square was having another one of his wonderful years, clocking in a gross return of 13.0% on a year-to-date basis through July, compared to the 3.4% return for the S&P 500 during the same period, until the current market volatility rocked his portfolio, driving all of his funds down into negative territory. In his letter to investors for the first half of the year, Ackman emphasized how his equity holdings are handpicked after rigorous research and thus the current upheaval should just be a small bump in the long run. Three companies that Pershing Square has a significant stake in include Herbalife Ltd. (NYSE:HLF), Mondelez International Inc (NASDAQ:MDLZ), and Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Ackman discussed each of them in his investor letter, and we have the details below.

Bill Ackman, Carl C. Icahn, William A. Ackman, Pershing Square Capital Management, Icahn Capital LP,

Professional investors like Ackman spend considerable time and money conducting due diligence on each company they invest in, which makes them the perfect investors to emulate. However, we also know that the returns of hedge funds on the whole have not been good for several years, underperforming the market. We analyzed the historical stock picks of these investors and our research revealed that the small-cap picks of these funds performed far better than their large-cap picks, which is where most of their money is invested and why their performances as a whole have been poor. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic the best ideas of the best fund managers on your own? A portfolio consisting of the 15 most popular small-cap stock picks among the funds we track has returned 118% and beaten the market by more than 60 percentage points since the end of August 2012 (see the details).

Bill Ackman
Bill Ackman
Pershing Square

Pershing Square acquired ownership of some 120.27 million shares of Mondelez International Inc (NASDAQ:MDLZ) in early August at about $40 per share, accounting for about 7.5% of the company’s outstanding stock. There are a number of things that lured Ackman to the $58 billion snack food and beverage company. The first and foremost is the vast room for margin improvement, which many of its competitors operate at. With 3G Capital taking over Heinz and Kraft, operating margins in the packaged food industry can generally be expected to stir, as the Brazilian multi-billion dollar global investment firm is known for the higher operational efficiency and coherent organizational design that it introduces to its takeover targets. Moreover, Mondelez International Inc (NASDAQ:MDLZ) has great room for improvement in these departments, as the combination of brands comprising it, including Cadbury, Nabisco, and LU Biscuit were never fully integrated according to Ackman. Additionally, Mondelez International Inc (NASDAQ:MDLZ)’s sales in emerging markets continue to grow despite a downturn in those economies, presenting strong growth prospects. Nelson Peltz‘s Trian Partners and Boykin Curry‘s Eagle Capital Management are two large stockholders of Mondelez International Inc (NASDAQ:MDLZ) within our database, holding some 48.03 million shares and 20.19 million shares respectively.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!